Skip to main content
Clinical Trials/ITMCTR2000003887
ITMCTR2000003887
Recruiting
未知

A randomized controlled trial for the effect of Modified Shenling Baizhu Powder on delaying the illness progress of COPD stable phase patients (GOLD 1-2 stages).

Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with a clinical diagnosis of stable COPD (GOLD stage 1\-2\); consistent with TCM lung qi deficiency syndrome;
  • 2\. No history of respiratory tract infection or acute exacerbation in the 4 weeks prior to randomization;
  • 3\. Those who are able to successfully perform pulmonary function measurements;
  • 4\. Patients are informed and sign written consent form.

Exclusion Criteria

  • 1\. Patients with chronic lung diseases in which intervention or treatment is required, such as interstitial lung diseasebronchial asthma, active tuberculosis, or bronchiectasis;
  • 2\. Patients with a combination of severe primary diseases, such as cardiovascular and cerebrovascular diseases, liver and kidney diseases, hematopoietic system diseases, endocrine diseases, severe mental disorders, malignant tumors;
  • 3\. Patients have evidence of alcohol or drug abuse, known or suspected allergy to the study drug or some of its components, and currently uses oral corticosteroids regularly;
  • 4\. Women who are breast\-feeding, pregnant or expecting a child;
  • 5\. Patients who have been involved in any other clinical study in the past 6 months;
  • 6\. Patients unable to successfully use a DPI or perform pulmonary function measurements.

Outcomes

Primary Outcomes

Not specified

Similar Trials